Literature DB >> 30498727

Sole causal therapy worsens outcome as compared to no therapy and combined causal and goal-directed supportive therapy in ovine septic shock.

Tim-Gerald Kampmeier1, Michael Hessler1, Philip Helge Arnemann1, Martin Westphal1,2, Laura Mareen Seidel1, Andrea Morelli3, Hugo Van Aken1, Sebastian Rehberg4, Christian Ertmer1.   

Abstract

BACKGROUND: There is clear evidence that early causal therapy improves outcome in sepsis and septic shock, whereas recent studies on supportive hemodynamic therapy have produced very conflictive results. The objective of the present study was to determine whether a supportive hemodynamic therapy guided by clinically relevant invasive monitoring improves survival and organ function in a high-lethality model of septic shock in sheep as compared to sole causal therapy including surgical and antimicrobial treatment.
METHODS: Twenty healthy ewes were anaesthetized and instrumented for hemodynamic surveillance. After laparotomy and fecal withdrawal from the caecum, animals were randomly assigned to one of four groups: sham, control, causal and combined therapy. In all groups but the sham group, feces were injected into the peritoneal cavity. Septic shock was defined as mean arterial pressure (MAP) ≤60 mmHg and arterial lactate concentration ≥1.8 mmol·L-1. Animals of the control group received no therapy, while the causal group received broad-spectrum antibiotic therapy and peritoneal lavage. The combined therapy group received causal therapy plus supportive hemodynamic therapy.
RESULTS: The sham animals showed no signs of systemic infection, while all other animals developed septic shock with arterial hypotension and lactic acidosis within 4.0 (4.0-6.8) hours. Induction of causal therapy did not impact on haemodynamics as compared to the control group. Notably, 50% of the control animals and none of the causal therapy animals survived the study. Combined therapy stabilized haemodynamics and improved organ function and survival as compared to control and causal therapy groups.
CONCLUSIONS: The present data suggest that sole causal sepsis therapy without hemodynamic support worsens outcome even more than natural evolution of sepsis and combined causal and supportive therapy. This underlines the importance of early hemodynamic stabilization in parallel with antibiotic and surgical treatment of the sepsis focus.

Entities:  

Keywords:  Causal therapy; septic shock; sheep; supportive therapy; survival

Year:  2018        PMID: 30498727      PMCID: PMC6230866          DOI: 10.21037/atm.2018.09.32

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


  23 in total

Review 1.  Clinical implications of antibiotic-induced endotoxin release in septic shock.

Authors:  P M Lepper; T K Held; E M Schneider; E Bölke; H Gerlach; M Trautmann
Journal:  Intensive Care Med       Date:  2002-05-30       Impact factor: 17.440

Review 2.  Antibiotic-induced release of endotoxin: a reappraisal.

Authors:  J C Hurley
Journal:  Clin Infect Dis       Date:  1992-11       Impact factor: 9.079

3.  Outcomes of patients with severe infection in Uganda according to adherence to the World Health Organization's Integrated Management of Adolescent and Adult Illness fluid resuscitation guidelines.

Authors:  Abdallah Amir; Kacie J Saulters; Rose Muhindo; Christopher C Moore
Journal:  J Crit Care       Date:  2017-04-26       Impact factor: 3.425

4.  Time to Treatment and Mortality during Mandated Emergency Care for Sepsis.

Authors:  Christopher W Seymour; Foster Gesten; Hallie C Prescott; Marcus E Friedrich; Theodore J Iwashyna; Gary S Phillips; Stanley Lemeshow; Tiffany Osborn; Kathleen M Terry; Mitchell M Levy
Journal:  N Engl J Med       Date:  2017-05-21       Impact factor: 91.245

5.  Differential alterations in systemic and regional oxygen delivery and consumption during the early and late stages of sepsis.

Authors:  S Yang; W G Cioffi; K I Bland; I H Chaudry; P Wang
Journal:  J Trauma       Date:  1999-10

6.  Prevention of Jarisch-Herxheimer reactions by treatment with antibodies against tumor necrosis factor alpha.

Authors:  D Fekade; K Knox; K Hussein; A Melka; D G Lalloo; R E Coxon; D A Warrell
Journal:  N Engl J Med       Date:  1996-08-01       Impact factor: 91.245

Review 7.  Experimental models of sepsis and their clinical relevance.

Authors:  Luiz F Poli-de-Figueiredo; Alejandra G Garrido; Naomi Nakagawa; Paulina Sannomiya
Journal:  Shock       Date:  2008-10       Impact factor: 3.454

8.  Antibiotic-induced release of endotoxin from bacteria in vitro.

Authors:  H A Crosby; J F Bion; C W Penn; T S Elliott
Journal:  J Med Microbiol       Date:  1994-01       Impact factor: 2.472

9.  Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012.

Authors:  R P Dellinger; Mitchell M Levy; Andrew Rhodes; Djillali Annane; Herwig Gerlach; Steven M Opal; Jonathan E Sevransky; Charles L Sprung; Ivor S Douglas; Roman Jaeschke; Tiffany M Osborn; Mark E Nunnally; Sean R Townsend; Konrad Reinhart; Ruth M Kleinpell; Derek C Angus; Clifford S Deutschman; Flavia R Machado; Gordon D Rubenfeld; Steven Webb; Richard J Beale; Jean-Louis Vincent; Rui Moreno
Journal:  Intensive Care Med       Date:  2013-01-30       Impact factor: 17.440

10.  Translational research in sepsis - an ultimate challenge?

Authors:  Tim G Kampmeier; Christian Ertmer; Sebastian Rehberg
Journal:  Exp Transl Stroke Med       Date:  2011-11-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.